P.D. Winocour

1.7k citations

57 papers · 1.4k indexed · h-index 20

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Hematology top 5%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms

Papers in

Hematology 18
- Platelet Disorders and Treatments 9
- Blood Coagulation and Thrombosis Mechanisms 8
Internal Medicine 4

Co-authors: R L Kinlough-Rathbone John A. Colwell Cezary Watała Perry V. Halushka J. F. Mustard Maria F. Lopes‐Virella Dennis Perry Mary Richardson
Journals: Thrombosis and Haemostasis (9 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Diabetes (4 papers)Atherosclerosis (4 papers)Thrombosis Research (4 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

P.D. Winocour

57 papers receiving 1.3k citations

Peers

Countries citing papers authored by P.D. Winocour

Since Specialization

Citations

This map shows the geographic impact of P.D. Winocour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.D. Winocour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.D. Winocour more than expected).

Fields of papers citing papers by P.D. Winocour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.D. Winocour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.D. Winocour. The network helps show where P.D. Winocour may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P.D. Winocour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.D. Winocour Line = papers co-authored together P.D. Winocour links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AEG35156, a XIAP antisense oligonucleotide, suppresses XIAP levels in targeted tissues isolated from pre-clinical models and from patients Cancer Research ·Eric C. LaCasse, Stephen Morris, Tim Ward, 朋子野澤, L Robson, 裕資川本, Danielle Méthot, Lori Jerome, P.D. Winocour, John W. Gillard, Jacques Jolivet, Duncan I. Jodrell, Malcolm Ranson, Jon P. Durkin	2006	3
2	Application of XIAP Antisense to Cancer and Other Proliferative Disorders: Development of AEG35156/ GEM®640 Annals of the New York Academy of Sciences ·Eric C. LaCasse, Ekambar R. Kandimalla, P.D. Winocour, Timothy J. Sullivan, Sudhir Agrawal, John W. Gillard, Jon P. Durkin	2005	52
3	Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residues Bioorganic & Medicinal Chemistry Letters ·E. Del Olmo, J.E.B. Adegas, Benoit Bachand, Giulia Zanchetta, Lorraine Leblond, P.D. Winocour, Jeremy J. Edmunds, John R. Rubin, M. Arshad Siddiqui	2001	14
4	Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors Bioorganic & Medicinal Chemistry Letters ·Benoit Bachand, Гончаров П. В., J.E.B. Adegas, Jeremy J. Edmunds, P.D. Winocour, Lorraine Leblond, M. Arshad Siddiqui	2001	23
5	Incorporation of an Asp-Ser Sequence to Form an RGDS-like Motif in Hirutonin Thrombosis Research ·M. Effati, Lorraine Leblond, P.D. Winocour, Dana V. Devine, Maria I.C. Gyöngyössy‐Issa	2000	2
6	In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors Thrombosis Research ·Lorraine Leblond, Brigitte Grouix, 中島史佳, Achmad Hifni, M. Arshad Siddiqui, P.D. Winocour	2000	7
7	The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1 Bioorganic & Medicinal Chemistry Letters ·Wayne L. Cody, 海雲上司, Annette M. Doherty, Jeremy J. Edmunds, John X. He, Lakshmi Narasimhan, YURI FERREIRA CORRÊA, Stephen T. Rapundalo, John R. Rubin, Lucínio José Souza da Silva, J.E.B. Adegas, P.D. Winocour, M. Arshad Siddiqui	1999	10
8	The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2 Bioorganic & Medicinal Chemistry Letters ·Wayne L. Cody, Corinne E. Augelli‐Szafran, Cátia Augustin, 海雲上司, Annette M. Doherty, Jeremy J. Edmunds, John X. He, Lakshmi Narasimhan, Simonetta Terio, YURI FERREIRA CORRÊA, Stephen T. Rapundalo, John R. Rubin, Lucínio José Souza da Silva, Lorraine Leblond, P.D. Winocour, M. Arshad Siddiqui	1999	3
9	Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 Modifications Bioorganic & Medicinal Chemistry Letters ·YURI FERREIRA CORRÊA, Cátia Augustin, 海雲上司, Wayne L. Cody, John DiMaio, Annette M. Doherty, Jeremy J. Edmunds, John X. He, Debra R. Holland, E. Del Olmo, Vanessa Plantier, Lakshmi Narasimhan, John R. Rubin, Stephen T. Rapundalo, M. Arshad Siddiqui, Ghena Hamoudi Hussein Alzubaidy, J.E.B. Adegas, P.D. Winocour	1998	18
10	Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications Bioorganic & Medicinal Chemistry Letters ·J.E.B. Adegas, Corinne E. Augelli‐Szafran, Benoit Bachand, Cátia Augustin, John DiMaio, Annette M. Doherty, Jeremy J. Edmunds, Lorraine Leblond, E. Del Olmo, Lakshmi Narasimhan, Simonetta Terio, John R. Rubin, Гончаров П. В., P.D. Winocour, M. Arshad Siddiqui	1998	14
11	Comparative catabolism of prothrombin and antithrombin in normal and alloxan-diabetic rabbits Metabolism ·Mark W.C. Hatton, Alma Rosa Aguilar, M. A. Blajchman, P. C. DAY, P.D. Winocour, Mostafa Shafei	1997	1
12	Spontaneous Diabetes in BB Wistar Rats Causes Small Increases in the Early Proliferative Response of Smooth Muscle Cells in Re-injured Aortae Experimental and Molecular Pathology ·P.D. Winocour, Trevor W. Logan	1995	9
13	Proteoglycan Alterations in the Aortic Intima-Media of Alloxan-Diabetic Rabbits: An Ultrastructural and Biochemical Study Experimental and Molecular Pathology ·Mary Richardson, Оlha Kuznetsova, Tahali Mendoza-Oliveros, P.D. Winocour, M.W.C. Hatton	1995	6
14	Platelet turnover in advanced diabetes European Journal of Clinical Investigation ·P.D. Winocour	1994	33
15	Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits. PubMed ·M.W.C. Hatton, Alma Rosa Aguilar, Shinta Pramuningtyas, Michael Richardson, P.D. Winocour	1993	11
16	On Glucose Transport and Non-enzymic Glycation of Proteins In Vivo Journal of Theoretical Biology ·Mark W.C. Hatton, Mary Richardson, P.D. Winocour	1993	16
17	Increased platelet, but unaltered fibrinogen, accumulation in experimental thrombi in alloxan-induced diabetic rabbits Experimental and Molecular Pathology ·P.D. Winocour, M.W.C. Hatton, Mary Richardson	1992	4
18	The Relationship of Chemical Modification of Membrane Proteins and Plasma Lipoproteins to Reduced Membrane Fluidity of Erythrocytes from Diabetic Subjects Clinical Chemistry and Laboratory Medicine (CCLM) ·Cezary Watała, P.D. Winocour	1992	31
19	A member of the selectin family (gmp-140/padgem) is expressed on thrombin-stimulated rat platelets in vitro Comparative Biochemistry and Physiology Part A Physiology ·P.D. Winocour, A szerk., S Parmentier, John L. McGregor	1992	7
20	Thrombin binding to platelets from hypercholesterolaemic rats Atherosclerosis ·P.D. Winocour, R L Kinlough-Rathbone, Margaret L. Rand, Mark W.C. Hatton, J. F. Mustard	1988	6

About P.D. Winocour

P.D. Winocour is a scholar working on Hematology, Internal Medicine, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Blood properties and coagulation (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Platelet Disorders and Treatments (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Chemical Synthesis and Analysis (7 papers), Pharmacology and Obesity Treatment (6 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Internal Medicine (107 citations), Hematology (270 citations), Endocrinology, Diabetes and Metabolism (384 citations), Cardiology and Cardiovascular Medicine (493 citations) and Clinical Biochemistry (100 citations). P.D. Winocour has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include R L Kinlough-Rathbone, John A. Colwell, Cezary Watała, Perry V. Halushka, J. F. Mustard, Maria F. Lopes‐Virella, Dennis Perry, Mary Richardson, M.W.C. Hatton and Lorraine Leblond. Their work appears in journals such as Thrombosis and Haemostasis, Bioorganic & Medicinal Chemistry Letters, Diabetes, Atherosclerosis and Thrombosis Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact